Interbody Fusion Devices in the Treatment of Cervicobrachial Syndrome

NCT ID: NCT01511445

Last Updated: 2017-05-08

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-12-31

Study Completion Date

2015-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study randomizes neck and arm pain patients being treated with discectomy and anterior interbody fusion into two groups: one to receive a new ceramic implant and a control group with a more traditional plastic implant. The study will measure and compare pain and disability improvement with the two products over a period of two years. The fusion status will also be judged with plane x-rays and one CT scan.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Radiating Pain Myelopathy Cervicobrachial Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ACDF with PEEK interbody cage

Anterior cervical discectomy and fusion (ACDF) with an interbody spacer made from polyetheretherketone (PEEK) plastic. The open space in the center of the cage is to be filled with local autologous bone harvested during the decompression phase of the procedure.

Group Type ACTIVE_COMPARATOR

Anterior cervical discectomy and fusion (ACDF) with PEEK Cage

Intervention Type DEVICE

Anterior cervical discectomy and fusion with the use of a PEEK plastic interbody spacer

ACDF with Valeo CSC Ceramic Cage

ACDF with the Valeo CSC cage, a silicon nitride ceramic interbody cage. The center area of the cage is filled with porous silicon nitride. No autologous bone is used; the cage is soaked in patient blood.

Group Type EXPERIMENTAL

Anterior cervical discectomy and fusion (ACDF) with a Valeo CSC Cage

Intervention Type DEVICE

Anterior cervical discectomy and fusion with a Valeo ceramic cage interbody spacer.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Anterior cervical discectomy and fusion (ACDF) with PEEK Cage

Anterior cervical discectomy and fusion with the use of a PEEK plastic interbody spacer

Intervention Type DEVICE

Anterior cervical discectomy and fusion (ACDF) with a Valeo CSC Cage

Anterior cervical discectomy and fusion with a Valeo ceramic cage interbody spacer.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Medicrea Manta or similar PEEK cage Valeo CSC (Cancellous Structured Ceramic) Silicon Nitride ceramic

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 75 years
* Radicular signs and symptoms in one or both arms (i.e., pain, paraesthesiae or paresis in a specific nerve root distribution) or symptoms and signs of acute or chronic myelopathy.
* At least 8 weeks prior conservative treatment (i.e., physical therapy, pain medication)
* Radiographic diagnosis of cervical disc herniation and/or osteophyte at 1 level (C3-C4 to C7-T1) in accordance with clinical signs and symptoms
* Ability and willingness to comply with project requirements
* Written informed consent given by the subject or the subject's legally authorised representative

Exclusion Criteria

* Previous cervical surgery (either anterior or posterior)
* Increased motion on dynamic studies (\> 3 mm)
* Severe segmental kyphosis of the involved disc level (\> 7 degrees)
* Patient cannot be imaged with MRI
* Neck pain only (without radicular or medullary symptoms)
* Infection
* Metabolic and bone diseases (osteoporosis, severe osteopenia)
* Neoplasma or trauma of the cervical spine
* Spinal anomaly (Klippel Feil, Bechterew, OPLL)
* Severe mental or psychiatric disorder
* Inadequate Dutch language
* Planned (e)migration abroad in the year after inclusion
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Amedica Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mark P Arts, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Medical Center Haaglanden

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medical Center Haaglanden

The Hague, , Netherlands

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NL36103.098.11

Identifier Type: REGISTRY

Identifier Source: secondary_id

Amedica 2010-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

rhBMP-2 in Cervical Arthrodesis
NCT02178605 COMPLETED
In-house Produced PMMA- Versus PEEK-cages
NCT01607775 COMPLETED PHASE1/PHASE2
Cervical Spondylotic Myelopathy Surgical Trial
NCT02076113 ACTIVE_NOT_RECRUITING NA
Allogeinic Bone Paste
NCT04605120 UNKNOWN NA
Posterior Cervical Fixation Study
NCT04770571 ENROLLING_BY_INVITATION